The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under 65. Pfizer is reviewing the plan, while officials call for more evidence on booster effectiveness.

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not needed to conduct additional tests on each year’s updated vaccine. It's similar to the way the annual flu shot is updated to target the newest influenza strains,

Peter A. McCullough, a former cardiologist who promoted unproven treatments like ivermectin and hydroxychloroquine at the height of the pandemic, posted a video to Instagram claiming that Biden’s cancer was “turbo cancer.”

Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 variant LP.

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the virus, and those older than age 65.

Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

Three Georgians were sentenced Thursday for their participation in a scheme to defraud the Georgia Department of Labor, out of tens of millions of dollars in benefits meant to assist unemployed individuals during the COVID-19 pandemic.

The Iowa Supreme Court will allow families of four Tyson Waterloo plant workers who died of COVID in 2020 to go forward with negligence suits against executives and supervisiors, but not against the company.